RE:Could it be the 4% TFC-1067 data point result I remain very open to the possibility that we see something not related to RF and 0.4% this week, before March 9 potential Rodan and Fields market announcement of their next product line or version updates of existing line ups.
I have the view that sglt2 clinical trial results and any pets deal as a separate item both remain as areas that can theoretically and realistically be wrapped up and reported on very short notice should their partners be also ready. Either one would be fine with me.
I will leave my opinion at that. This week and next week there will be significant eyes on the potential prize(s) and will be interesting to see if this period where we break through the two year high.